Beta
Ceftibuten
medication Under reviewA third-generation cephalosporin antibiotic used to treat various bacterial infections.
Research summary
Scientific evidence from phase 1 studies in healthy humans demonstrates ceftibuten's favorable pharmacokinetics, including dose-proportional exposure and minimal accumulation at higher doses up to 1200 mg single or 800 mg multiple dosing. Safety profiles indicate good tolerability, though mild gastrointestinal and systemic adverse events occur. No studies in healthy subjects show benefits for general health applications beyond safety and PK data, as research focuses on its antibiotic properties in clinical settings.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research
No studies found yet. Request research to discover relevant studies.
Community updates
No updates yet for this supplement.
Be the first to share your experience!